Northern Trust Corp Lineage Cell Therapeutics, Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 510,462 shares of LCTX stock, worth $632,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares

510,462

Previous 1,539,586 66.84%

Holding current value

$632,972

Previous $692,000 32.95%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$0.39 - $1.13 $401,358 - $1.16 Million	-1,029,124 Reduced 66.84%	510,462 $464,000
Q1 2025 May 13, 2025	BUY	$0.45 - $0.72 $119,292 - $190,867	265,094 Added 20.8%	1,539,586 $692,000
Q4 2024 Feb 14, 2025	SELL	$0.5 - $0.95 $40 - $76	-81 Reduced 0.01%	1,274,492 $637,000
Q3 2024 Nov 13, 2024	BUY	$0.8 - $1.12 $66,604 - $93,245	83,255 Added 6.99%	1,274,573 $1.16 Million
Q2 2024 Aug 14, 2024	SELL	$0.89 - $1.47 $36,692 - $60,605	-41,228 Reduced 3.34%	1,191,318 $1.19 Million
Q1 2024 May 14, 2024	BUY	$0.86 - $1.48 $32,131 - $55,295	37,362 Added 3.13%	1,232,546 $1.82 Million
Q4 2023 Feb 13, 2024	SELL	$0.91 - $1.35 $7,983 - $11,843	-8,773 Reduced 0.73%	1,195,184 $1.3 Million
Q3 2023 Nov 13, 2023	BUY	$1.16 - $1.53 $116,956 - $154,262	100,825 Added 9.14%	1,203,957 $1.42 Million
Q2 2023 Aug 11, 2023	BUY	$1.26 - $1.53 $1.09 Million - $1.33 Million	866,049 Added 365.29%	1,103,132 $1.56 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $1.53 $16,359 - $20,858	13,633 Added 6.1%	237,083 $355,000
Q3 2022 Nov 14, 2022	BUY	$1.13 - $1.77 $24,492 - $38,364	21,675 Added 10.74%	223,450 $252,000
Q2 2022 Aug 12, 2022	SELL	$1.12 - $1.61 $928,518 - $1.33 Million	-829,034 Reduced 80.43%	201,775 $319,000
Q1 2022 May 13, 2022	SELL	$1.21 - $2.48 $60,639 - $124,285	-50,115 Reduced 4.64%	1,030,809 $1.59 Million
Q4 2021 Feb 08, 2022	SELL	$1.84 - $2.68 $766,733 - $1.12 Million	-416,703 Reduced 27.82%	1,080,924 $2.65 Million
Q3 2021 Nov 15, 2021	SELL	$2.26 - $2.86 $296,335 - $375,008	-131,122 Reduced 8.05%	1,497,627 $3.77 Million
Q2 2021 Aug 13, 2021	BUY	$2.17 - $3.0 $2.89 Million - $4 Million	1,332,456 Added 449.71%	1,628,749 $4.64 Million
Q1 2021 May 12, 2021	BUY	$1.77 - $3.1 $60,647 - $106,218	34,264 Added 13.08%	296,293 $696,000
Q4 2020 Feb 11, 2021	SELL	$0.95 - $1.83 $6,675 - $12,859	-7,027 Reduced 2.61%	262,029 $461,000
Q3 2020 Nov 16, 2020	BUY	$0.75 - $1.09 $19,440 - $28,253	25,921 Added 10.66%	269,056 $252,000
Q2 2020 Aug 14, 2020	SELL	$0.71 - $1.18 $737,988 - $1.23 Million	-1,039,421 Reduced 81.04%	243,135 $211,000
Q1 2020 May 14, 2020	BUY	$0.6 - $1.58 $74,913 - $197,270	124,855 Added 10.78%	1,282,556 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$0.54 - $1.01 $23,575 - $44,094	-43,658 Reduced 3.63%	1,157,701 $1.03 Million
Q3 2019 Nov 13, 2019	BUY	$0.85 - $1.24 $1.02 Million - $1.49 Million	1,201,359 New	1,201,359 $1.18 Million

Others Institutions Holding LCTX

# of Institutions

142

Shares Held

106M

Call Options Held

368K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $210M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Lineage Cell Therapeutics, Inc. Transaction History